Skip to content

    Edwards Lifesciences Corp

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $1.37B
    $1.35B
    $1.39B
    $1.41B
    $1.53B
    +11.9%
    $1.55B
    +14.7%
    $1.57B
    +13.3%
    $1.65B
    +16.7%
    Strengthening
    Operating Profit
    $366.50M
    $350.60M
    $312.60M
    $394.80M
    $411.20M
    +12.2%
    $307.10M
    -12.4%
    $151.10M
    -51.7%
    $477.60M
    +21.0%
    Weakening
    Net Profit
    $366.30M
    $3.07B
    $385.60M
    $358.00M
    $333.20M
    -9.0%
    $291.10M
    -90.5%
    $91.20M
    -76.3%
    $380.70M
    +6.3%
    Weakening
    EPS
    $0.61
    $5.14
    $0.65
    $0.61
    $0.57
    -6.6%
    $0.50
    -90.3%
    $0.66
    +8.2%
    Weakening
    Other Income
    $17.50M
    $52.20M
    $77.50M
    $39.10M
    -$11.00M
    -162.9%
    $41.30M
    -20.9%
    -$60.70M
    -178.3%
    -$18.60M
    -147.6%
    Weakening
    Interest
    Depreciation
    Profit before Tax
    $384.00M
    $402.80M
    $390.10M
    $433.90M
    $400.20M
    +4.2%
    $348.40M
    -13.5%
    $90.40M
    -76.8%
    $459.00M
    +5.8%
    Weakening
    MarginsOPM
    26.8%
    25.9%
    22.6%
    27.9%
    26.8%
    +0.3%
    19.8%
    -23.6%
    9.6%
    -57.3%
    29.0%
    +3.6%
    Weakening
    Tax
    5.2%
    10.1%
    11.6%
    16.2%
    16.1%
    +208.4%
    16.1%
    +59.4%
    29.0%
    +150.7%
    17.1%
    +5.3%
    Strengthening
    ReturnsROIC
    2.4%
    20.1%
    2.5%
    2.3%
    2.2%
    -9.0%
    1.9%
    -90.5%
    0.6%
    -76.3%
    2.5%
    +6.3%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$714.10M$1.18B$1.18B$862.80M$769.00M$1.13B$3.05B$2.94B$2.45B
    Short-Term Investments
    Total Current Assets$2.29B$2.98B$3.09B$3.18B$3.10B$4.04B$6.29B$6.74B$6.23B
    Net PP&E$867.50M$1.14B$1.49B$1.64B$1.73B$1.68B$1.78B$1.91B$1.92B
    Goodwill$1.11B$1.17B$1.17B$1.17B$1.06B$1.15B$1.78B$1.77B$1.82B
    Intangibles$343.20M$336.50M$331.40M$323.60M$285.20M$399.40M$1.18B$1.13B$1.23B
    Total Assets$5.32B$6.49B$7.24B$8.50B$8.29B$9.36B$13.06B$13.70B$13.32B
    LiabilitiesTotal Current Liabilities$876.60M$902.40M$893.90M$1.03B$1.02B$1.20B$1.51B$1.81B$1.41B
    Short-Term Debt$0
    Long-Term Debt$593.80M$594.40M$595.00M$595.70M$596.30M$597.00M$597.70M$598.30M$598.50M
    Long-Term Leases$58.90M$72.70M$69.10M$69.50M$65.20M$78.90M$82.60M$80.10M
    Total Liabilities$2.18B$2.34B$2.66B$2.67B$2.49B$2.64B$2.99B$3.36B$2.99B
    EquityCommon Stock & APIC$215.20M$218.10M$636.40M$642.00M$646.30M$650.50M$654.80M$658.70M$660.00M
    Retained Earnings$2.69B$3.74B$4.57B$6.07B$7.59B$8.99B$13.17B$14.24B$14.62B
    Total Equity$3.14B$4.15B$4.57B$5.84B$5.81B$6.65B$10.00B$10.34B$10.33B
    HighlightsNet Cash / (Debt)$120.30M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$926.70M$1.18B$1.05B$1.73B$1.22B$895.80M$542.30M$1.60B$1.36B
    Cash from Investing$76.70M-$595.80M-$531.10M-$1.72B$252.30M$173.80M$2.31B-$712.90M-$891.00M
    Cash from Financing-$1.10B-$115.60M-$486.90M-$356.30M-$1.58B-$711.00M-$983.00M-$956.80M-$1.15B
    SummaryCapital Expenditure-$238.70M-$254.40M-$407.00M-$325.80M-$244.60M-$253.00M-$252.40M-$260.20M-$269.10M
    Free Cash Flow$688.00M$928.50M$647.30M$1.41B$973.60M$642.80M$289.90M$1.33B$1.09B
    FCF Margin18.5%21.4%14.8%26.9%21.8%12.8%5.3%22.0%17.3%